22138757
9780309212809
Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II is the author of 'Risk-Characterization Framework for Decision-Making at the Food and Drug Administration', published 2011 under ISBN 9780309212809 and ISBN 0309212804.
[read more]